These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7535146

  • 1. Peripheral blood stem cells: in vivo biology and therapeutic potential.
    Scheding S, Brugger W, Mertelsmann R, Kanz L.
    Stem Cells; 1994; 12 Suppl 1():203-10; discussion 211. PubMed ID: 7535146
    [Abstract] [Full Text] [Related]

  • 2. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
    Haas R, Ehrhardt R, Witt B, Goldschmidt H, Hohaus S, Pförsich M, Ehrlich H, Färber L, Hunstein W.
    Bone Marrow Transplant; 1993 Dec; 12(6):643-9. PubMed ID: 7511017
    [Abstract] [Full Text] [Related]

  • 3. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 4. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 5. Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients.
    Kolbe K, Peschel C, Rupilius B, Després D, Burger K, Sklenar I, Färber L, Huber C, Derigs HG.
    Bone Marrow Transplant; 1997 Dec; 20(12):1027-32. PubMed ID: 9466274
    [Abstract] [Full Text] [Related]

  • 6. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [Abstract] [Full Text] [Related]

  • 7. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R, Murea S.
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 9. Peripheral blood stem cell mobilization with chemotherapy and granulocyte-colony stimulating factor in patients with hematological malignancies.
    Watanabe S, Mukaiyama T, Ogawa Y, Kawada H, Ichikawa Y.
    Tokai J Exp Clin Med; 1994 Dec; 19(3-6):143-55. PubMed ID: 7570686
    [Abstract] [Full Text] [Related]

  • 10. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 11. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 12. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
    Sampol Mayol A, Besalduch Vital J, Galmés Llodrá A, Bargay Lleonart J, Matamoros Flori N, Morey Sureda M, Novo García A, Mascaró Riera M, Gonzaléz Bach E, Martínez García P.
    Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M, Hilgenfeld E, Fietz T, Hoppe B, Koenigsmann M, Hoffmann M, Knauf WU, Cassens U, Sibrowski W, Kienast J, Thiel E, Berdel WE.
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
    Silva MR, Parreira A, Ascensão JL.
    Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
    Spitzer G, Adkins D, Mathews M, Velasquez W, Bowers C, Dunphy F, Kronmueller N, Niemeyer R, McIntyre W, Petruska P.
    Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
    [Abstract] [Full Text] [Related]

  • 18. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
    Kiss JE, Rybka WB, Winkelstein A, deMagalhaes-Silverman M, Lister J, D'Andrea P, Ball ED.
    Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238
    [Abstract] [Full Text] [Related]

  • 19. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P, Pawloski D, Stellberg W, Schröder JK, Seeber S.
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [Abstract] [Full Text] [Related]

  • 20. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ.
    Cancer; 2000 Aug 01; 89(3):680-9. PubMed ID: 10931469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.